Australia markets closed

PharmaEngine, Inc. (4162.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
93.70-0.80 (-0.85%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 13.46B
Enterprise value 9.77B
Trailing P/E 49.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.63
Price/book (mrq)3.41
Enterprise value/revenue 12.78
Enterprise value/EBITDA 28.09

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 30.43%
S&P500 52-week change 326.24%
52-week high 3122.50
52-week low 379.80
50-day moving average 393.38
200-day moving average 397.82

Share statistics

Avg vol (3-month) 3569.31k
Avg vol (10-day) 3706.6k
Shares outstanding 5143.68M
Implied shares outstanding 6146.13M
Float 892.03M
% held by insiders 120.18%
% held by institutions 121.51%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.13%
Trailing annual dividend rate 31.50
Trailing annual dividend yield 31.59%
5-year average dividend yield 42.04
Payout ratio 4104.71%
Dividend date 3N/A
Ex-dividend date 415 Aug 2023
Last split factor 21199.953:1000
Last split date 326 July 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 36.00%
Operating margin (ttm)40.97%

Management effectiveness

Return on assets (ttm)4.06%
Return on equity (ttm)6.96%

Income statement

Revenue (ttm)763.81M
Revenue per share (ttm)5.32
Quarterly revenue growth (yoy)-2.30%
Gross profit (ttm)N/A
EBITDA 264.87M
Net income avi to common (ttm)275M
Diluted EPS (ttm)1.91
Quarterly earnings growth (yoy)0.40%

Balance sheet

Total cash (mrq)3.71B
Total cash per share (mrq)25.82
Total debt (mrq)12.9M
Total debt/equity (mrq)0.33%
Current ratio (mrq)36.85
Book value per share (mrq)27.46

Cash flow statement

Operating cash flow (ttm)251.1M
Levered free cash flow (ttm)131.42M